South Sudan vs Venezuela, Bolivarian Republic of: Average cost of multi drug-resistant tuberculosis treatment
South Sudan
682 constant 2022 US$
in 2024
Venezuela, Bolivarian Republic of
674 constant 2022 US$
in 2024
South Sudan rank
69th
Venezuela, Bolivarian Republic of rank
70th
Average cost of multi drug-resistant tuberculosis treatment over time
- South Sudan
- Venezuela, Bolivarian Republic of
How they compare
South Sudan currently reports 682 constant 2022 US$ against 674 constant 2022 US$ in Venezuela, Bolivarian Republic of, a difference of 8 constant 2022 US$.
The two have swapped places 2 times across 6 shared years of data; in 2019 it was South Sudan ahead.
South Sudan ranks 69th and Venezuela, Bolivarian Republic of ranks 70th of 92 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Sudan | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,678 constant 2022 US$ | 806 constant 2022 US$ | 872 constant 2022 US$ | South Sudan |
| 2020s | 2,265 constant 2022 US$ | 1,372 constant 2022 US$ | 893 constant 2022 US$ | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, South Sudan or Venezuela, Bolivarian Republic of?
- South Sudan, at 682 constant 2022 US$ against 674 constant 2022 US$ in Venezuela, Bolivarian Republic of as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between South Sudan and Venezuela, Bolivarian Republic of?
- 8 constant 2022 US$, with South Sudan ahead.
- How many years of comparable data are there for South Sudan and Venezuela, Bolivarian Republic of?
- 6 years are reported by both, from 2019 to 2024.
- How do South Sudan and Venezuela, Bolivarian Republic of rank globally for average cost of multi drug-resistant tuberculosis treatment?
- South Sudan ranks 69th and Venezuela, Bolivarian Republic of ranks 70th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.